ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661421; 2) Community: the network communities that were significantly associated with the response to NSC 661421; 3) Molecule: the relationships between components within communities and NSC 661421; 4) MDR: the compounds that were significantly associated with the NSC 661421.

NSC Compound Enrichment Correlation
NSC 10848 Null 0.0454469012959173 -0.069584679
NSC 111533 Methoxycamptothecin 0.0454469012959173 -0.093546897
NSC 129943 (+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane 0.0454469012959173 -0.085646127
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0454469012959173 0.023060457
NSC 243022 Cinerubin A hydrochloride 0.0454469012959173 -0.061840334
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.0454469012959173 0.4254452
NSC 292596 Null 0.0454469012959173 0.53652511
NSC 3088 Chlorambucil 0.0454469012959173 0.03050299
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0454469012959173 0.45949545
NSC 603831 Acteoside 0.0454469012959173 -0.080615384
Total:60  Current:52    [First] [Prev] [Next] [Last]